Universal Health Services (UHS) is trading down at $175.43 (-0.93%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
One firm's current price target on Universal Health Services: $191 — 9% above the current $175. Each is tracked to its date and scored the same way a member's call is.
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $9.77B | $10.4B | $10.8B | $11.4B | $11.6B | $12.6B | $13.4B | $14.3B | $15.8B | $17.4B |
| Growth (year over year) | +8.0% | +6.6% | +3.5% | +5.6% | +1.6% | +9.4% | +6.0% | +6.6% | +10.8% | +9.7% |
| Operating income | $1.28B | $1.28B | $1.18B | $1.22B | $1.36B | $1.36B | $1.00B | $1.18B | $1.68B | $1.99B |
| Operating margin | 13.1% | 12.3% | 10.9% | 10.7% | 11.8% | 10.8% | 7.5% | 8.2% | 10.6% | 11.5% |
| Net income | $702.4M | $752.3M | $779.7M | $814.9M | $944.0M | $991.6M | $675.6M | $717.8M | $1.14B | $1.49B |
| Net margin | 7.2% | 7.2% | 7.2% | 7.2% | 8.2% | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% |
| EPS (diluted) | $7.14 | $7.81 | $8.31 | $9.13 | $10.99 | $11.82 | $9.14 | $10.23 | $16.82 | $23.10 |
| Balance sheet | ||||||||||
| Cash and equivalents | $33.7M | $74.4M | $105.2M | $61.3M | $1.22B | $115.3M | $102.8M | $119.4M | $126.0M | $137.8M |
| Total assets | $10.3B | $10.8B | $11.3B | $11.7B | $13.5B | $13.1B | $13.5B | $14.0B | $14.5B | $15.5B |
| Total liabilities | $5.72B | $5.71B | $5.80B | $6.09B | $7.07B | $6.90B | $7.53B | $7.77B | $7.72B | $8.19B |
| Long-term debt | $4.03B | $3.49B | $3.94B | $3.90B | $3.52B | $4.14B | $4.73B | $4.79B | $4.46B | $4.00B |
| Shareholders' equity | $4.53B | $4.99B | $5.39B | $5.50B | $6.32B | $6.09B | $5.92B | $6.15B | $6.67B | $7.28B |
| Cash flow | ||||||||||
| Operating cash flow | $1.33B | $1.25B | $1.27B | $1.44B | $2.36B | $883.7M | $996.0M | $1.27B | $2.07B | $1.86B |
| Capital expenditure | $519.9M | $557.5M | $665.0M | $634.1M | $731.3M | $855.7M | $734.0M | $743.1M | $943.8M | $1.02B |
| Free cash flow | $813.9M | $690.1M | $609.8M | $804.4M | $1.63B | $28.0M | $262.0M | $524.7M | $1.12B | $849.2M |
| Dividends paid | $38.9M | $38.2M | $37.3M | $53.0M | $17.3M | $65.9M | $58.4M | $55.5M | $53.3M | $51.3M |
| Share buybacks | $353.4M | $364.4M | $397.4M | $770.5M | $206.7M | $1.22B | $832.9M | $547.4M | $670.8M | $968.0M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.96B | $4.11B | $4.10B | $4.28B | $4.50B | $4.49B | $4.50B | $4.64B |
| Growth (year over year) | +11.2% | +11.1% | +6.7% | +9.6% | +13.4% | +9.1% | +9.6% | +8.3% |
| Operating income | $384.2M | $472.5M | $454.8M | $500.3M | $521.7M | $517.2M | $502.9M | $516.7M |
| Operating margin | 9.7% | 11.5% | 11.1% | 11.7% | 11.6% | 11.5% | 11.2% | 11.1% |
| Net income | $258.7M | $332.4M | $316.7M | $353.2M | $373.0M | $445.9M | $348.7M | $358.4M |
| Net margin | 6.5% | 8.1% | 7.7% | 8.2% | 8.3% | 9.9% | 7.8% | 7.7% |
| EPS (diluted) | $3.80 | $4.94 | $4.80 | $5.43 | $5.86 | $7.01 | $5.65 | $5.98 |
| Balance sheet | ||||||||
| Cash and equivalents | $106.1M | $126.0M | $126.8M | $137.6M | $112.9M | $137.8M | $119.0M | $138.8M |
| Total assets | $14.4B | $14.5B | $14.9B | $15.0B | $15.3B | $15.5B | $15.7B | $15.9B |
| Total liabilities | $7.67B | $7.72B | $8.00B | $7.90B | $8.11B | $8.19B | $8.15B | $8.35B |
| Long-term debt | $4.62B | $4.46B | $4.61B | $4.54B | $3.95B | $4.00B | $3.95B | $4.08B |
| Shareholders' equity | $6.61B | $6.67B | $6.79B | $7.03B | $7.17B | $7.28B | $7.46B | $7.51B |
| Cash flow | ||||||||
| Operating cash flow | $333.0M | $658.4M | $360.0M | $549.0M | $380.7M | $574.7M | $401.6M | $443.3M |
| Capital expenditure | $247.9M | $245.9M | $239.0M | $266.0M | $228.9M | $281.2M | $217.2M | $227.6M |
| Free cash flow | $85.0M | $412.5M | $121.0M | $283.0M | $151.8M | $293.5M | $184.5M | $215.7M |
| Dividends paid | $13.3M | $13.0M | $13.5M | $12.9M | $12.5M | $12.4M | $13.0M | $11.8M |
| Share buybacks | $182.6M | $250.2M | $223.4M | $155.2M | $237.4M | $352.0M | $163.8M | $320.8M |
From Universal Health Services's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Source: Wikipedia — Universal Health Services
Universal Health Services at 2026 Global Healthcare Conference: growth meets policy pressure
Universal Health Services at 2026 Global Healthcare Conference: growth meets policy pressure
Universal Health Realty Income Trust declares $0.75 dividend
Universal Health Realty Income Trust declares $0.75 dividend
Universal Health Services Stock: Analyst Estimates & Ratings
Universal Health Services Stock: Analyst Estimates & Ratings